December 14, 2015
BEIJING & SAN DIEGO -- Novogene, a leading global provider of genomic services and solutions, and Illumina, Inc. (NASDAQ: ILMN) today announced they have entered into an agreement to jointly develop advanced clinical applications in the fields of reproductive health and oncology based on next-generation sequencing (NGS) technology. The collaboration signals the increasing importance of [...]
PerkinElmer Launches Clinical Data Review Analytical Solution
December 14, 2015
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of its Clinical Data Review analytical solution. This offering provides medical monitors, safety review teams, biostatisticians, data managers, pharmacologists, and others who analyze clinical data a powerful advanced analytics solution for overcoming data review [...]
December 14, 2015
FREMONT, Calif. and LUXEMBOURG -- WaferGen Bio-systems (NASDAQ: WGBS) announced today that the Company has signed a collaboration agreement with the Luxembourg Institute of Health (LIH), a leading public medical research center that specializes in oncology, infectious diseases, immunology, and population health. LIH will provide laboratory facilities for the ICELL8™ Single-Cell System and use of [...]
December 14, 2015
Beijing & San Diego — Novogene, a leading global provider of genomic services and solutions, and Illumina, Inc. (NASDAQ: ILMN) announced they have entered into an agreement to jointly develop advanced clinical applications in the fields of reproductive health and oncology based on next-generation sequencing (NGS) technology. The collaboration signals the increasing importance of genomic [...]
New Innovations at AGU 2015 Extend the Boundaries of Isotope Analysis for Geosciences Research
December 14, 2015
SAN FRANCISCO -- AGU 2015 – Scientists engaged in climate research, biochemistry, forensics and oil/gas exploration can analyze the isotopic anatomy of molecules using a new high-resolution isotope ratio mass spectrometer. It enables scientists to access the direct conditions under which molecules were formed, transported, stored and degraded. Thermo Fisher Scientific will showcase this and [...]
December 14, 2015
MARCY L'ETOILE, France & SAN DIEGO -- bioMérieux, a world leader in the field of in vitrodiagnostics, and Illumina (Nasdaq: ILMN), a world leader in genomics, announce the launch of bioMérieux EpiSeqTM, an innovative next-generation sequencing (NGS) service dedicated to the epidemiological monitoring and control of healthcare-associated infections. The bioMérieux EpiSeqTM service is the first [...]
BASi Names Wendy Perrow to Board of Directors
December 14, 2015
WEST LAFAYETTE, IN – Bioanalytical Systems, Inc. (“BASi”) (NASDAQ:BASI) today announced that its board of directors unanimously elected Ms. Wendy Perrow, President and Chief Executive Officer at Alba Therapeutics, as a director effective December 10, 2015. This action brings the number of directors to seven. Dr. John B. Landis, BASI’s chairman of the board, commented, [...]
Transposagen, Inc. Licenses Broad Institute CRISPR/Cas9 Technology
December 11, 2015
LEXINGTON, Ky.-- Transposagen, Inc. announced that it has entered into a non-exclusive license agreement with the Broad Institute to access intellectual property related to the CRISPR/Cas9 gene editing system. "Transposagen is pleased to be able to provide innovative tools and services using the CRISPR/Cas9 gene editing technology," commented John Printen, CEO of Transposagen, Inc. "Combination [...]
Rapid DNA data utilized in court to obtain a conviction for the first time
December 10, 2015
Pleasanton, CA –– IntegenX announced today that for the first time in the U.S., results from its RapidHIT® System were used in court to obtain a conviction in an attempted murder case in Richland County, South Carolina. This represents a groundbreaking development in the field of Rapid DNA, as the RapidHIT System is the first [...]
December 10, 2015
San Antonio, Texas -- Local organizations BioBridge Global (BBG) and StemBioSys Inc. (SBS), a privately held development-stage biomedical company in the emerging field of stem cells and regenerative medicine are expanding their research collaboration with the goal of bringing a new source of stem cells to the research market. The deal will leverage the unique [...]
